Individualized surgical treatment of Chiari 1 malformation: A single-center experience.

Chiari 1 malformation Chiari Severity Index Chicago Chiari Outcome Scale Dural splitting Foramen magnum decompression Syrinx Tonsillar resection

Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
07 2023
Historique:
received: 18 04 2023
revised: 23 05 2023
accepted: 24 05 2023
medline: 12 6 2023
pubmed: 29 5 2023
entrez: 28 5 2023
Statut: ppublish

Résumé

To present our experience with an individualized surgical approach to treat Chiari malformation type 1. Based on (1) neurological symptoms, (2) the existence and extent of a syrinx and (3) the degree of the tonsillar descent we performed four types of approaches on a case-by-case basis in 81 patients: (1) foramen magnum decompression (FMD) with dura splitting (FMDds); (2) FMD with duraplasty (FMDdp); (3) FMD with duraplasty and tonsillar manipulation (FMDao); and (4) tonsillar resection/reduction (TR). Patient characteristics, Chiari Severity Index (CSI), fourth ventricular roof angle (FVRA) and Chicago Chiari Outcome Scale (CCOS) were analyzed. CCOS was between 13 and 16 points in 8/11 (73 %) patients after FMDds, 38/45 (84 %) patients after FMDdp, and 24/24 (100 %, one patient lost to follow-up) patients after TR. We experienced an overall complication rate of 13.6 % (11/81) in this series, whereas seven of these eleven complications (64 %) occurred in the FMDao group and the complication rate increased with the invasiveness of the approach (0 % FMDds; 4 % FMDdp; 12 % TR). Given the clear correlation between the extend of the approach and the complication rate the least invasive approach necessary to achieve clinical improvement should be selected. Due to the high complication rates, FMDao should not be used as a treatment option. The severity of the tonsillar descent, basilar invagination and current CM1 scores could be used to aid in the approach selection.

Identifiants

pubmed: 37245455
pii: S0303-8467(23)00219-6
doi: 10.1016/j.clineuro.2023.107803
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107803

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests None.

Auteurs

Farjad Khalaveh (F)

Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.

Irene Steiner (I)

Center for Medical Data Science, Institute of Medical Statistics, Medical University of Vienna, Vienna, Austria.

Andrea Reinprecht (A)

Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.

Thomas Czech (T)

Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.

Gregor Kasprian (G)

Department of Radiology, Division of Neuro, and Musculoskeletal Radiology, Medical University of Vienna, Vienna, Austria.

Karl Rössler (K)

Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.

Christian Dorfer (C)

Department of Neurosurgery, Medical University of Vienna, Vienna, Austria. Electronic address: christian.dorfer@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH